Support our Nation today - please donate here

£86 million boost to cancer radiotherapy services

27 Jan 2023 3 minute read
The Welsh Government has committed to a £86m investment to deliver new radiotherapy equipment

The Welsh Government has announced the investment of more than £86 million for new cancer treatment facilities, equipment, and software.

The new investment announced by Heath Minister Eluned Morgan, is part of a long-term programme in southeast Wales to transform how cancer services are delivered.

More than £48 million is being invested in state-of-the-art radiotherapy equipment, replacing the linear accelerator fleet located at Velindre Cancer Centre.

Eight of these machines will be replaced at the centre in Whitchurch, Cardiff – and two more will be housed at a brand new radiotherapy centre at Nevill Hall Hospital in Abergavenny between now and 2025.

The new £38 million Radiotherapy ‘Satellite’ Centre at Nevill Hall Hospital will be open by 2024 to improve access to radiotherapy for people living in the north and east of the catchment area of Velindre Cancer Centre.

District general hospitals

This work is progressing in line with the development of the wider networked clinical model of non-surgical cancer care, which includes the development of integrated acute oncology services at district general hospitals throughout the region.

Visiting the Velindre Cancer Centre, the Minister for Health and Social Services said: “The opening of a satellite radiotherapy centre in southeast Wales and our recapitalisation of radiotherapy equipment demonstrates our commitment to making significant investments in improving cancer services and outcomes in Wales.”

“The new satellite model will improve access to radiotherapy, servicing many of our most socio-economically disadvantaged communities along the heads of the valleys and northern Gwent.”

“This builds on recent investments in the development of the new Velindre Cancer Centre and similar investments in radiotherapy, treatment planning and diagnostic equipment in our southwest and north Wales cancer treatment centres.”

“This is part of our longer-term approach of ensuring people are able to access recommended radiotherapy techniques within cancer waiting time targets and professional access standards.”

State-of-the art

Chief Executive of Velindre University NHS Trust Steve Ham added: “Our new fleet of radiotherapy machines will be among the best in Europe and will deliver state-of-the-art treatment to cancer patients in South-East Wales and beyond.

“We are grateful to the Welsh Government for their investment and look forward to working with our partners to build better cancer services for generations to come. Our staff and patients are at the heart of our service development and we are extremely grateful for the dedication they continue to demonstrate to improving patient outcomes whilst delivering first-class care today.

“Alongside the development of the new Velindre Cancer Centre, this will allow us to keep pace with increasing demand as the number of people referred to us with cancer grows every year.”

Support our Nation today

For the price of a cup of coffee a month you can help us create an independent, not-for-profit, national news service for the people of Wales, by the people of Wales.

Notify of
Newest Most Voted
Inline Feedbacks
View all comments
Aled Rees
Aled Rees
1 year ago

What about mid and north Wales

1 year ago
Reply to  Aled Rees

Good question. I suspect you’d be told that the population of Mid Wales has been factored into plans and figures for Abergavenny and Swansea ( either Singleton or Morriston). What doesn’t get factored in is the long journeys even if you are using your own vehicle and the therapy saps energy after a week or two. Not so bad if you are living along the M4 corridor or the A55 but anyone more than 30 minutes off those corridors is going to need assistance with driving etc.

Our Supporters

All information provided to Nation.Cymru will be handled sensitively and within the boundaries of the Data Protection Act 2018.